JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Index

Current Issue 2024/2/1

Original Article
Effect of vitamin D on prognosis in patients with gastric cancer

Published: 12 Feb 2024

Citation: Sezgin Y, Aydın İ, Biçer A, Can A. Effect of vitamin D on prognosis in patients with gastric cancer. J Curr Hematol Oncol Res. 2024;2(1):1-5.

Original Article
Do mean platelet volume and platelet count vary on a daily or gender basis?

Published: 12 Feb 2024

Citation: Candar Ö, Ekinci Ö, Doğan A, Ebinç S. Do mean platelet volume and platelet count vary on a daily or gender basis? J Curr Hematol Oncol Res. 2024;2(1):6-9.

Original Article
Factors affecting prognosis in myelodysplastic syndrome: an 11 years’ experience from a tertiary care center

Published: 12 Feb 2024

Citation: Doğan E, Küçükoğlu E, Keklik M. Factors affecting prognosis in myelodysplastic syndrome: an 11 years’ experience from a tertiary care center. J Curr Hematol Oncol Res. 2024;2(1):10-14.

Original Article
Comparison of efficacy and tolerability of single agent and double agent chemotherapy regimens in first-line treatment of elderly patients with her-2 negative metastatic gastric cancer

Published: 12 Feb 2024

Citation: Güner G, Ürün M. Comparison of efficacy and tolerability of single agent and double agent chemotherapy regimens in first-line treatment of elderly patients with HER-2 negative metastatic gastric cancer. J Curr Hematol Oncol Res. 2024;2(1):15-19.

Case Report
Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis

Published: 12 Feb 2024

Citation: Çelik S, Kaynar L. Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis. J Curr Hematol Oncol Res. 2023; 1(1): 15-17.

Letter to the Editor
Contributions of ELN2022 update and new genetic analysis tests in the risk assesment and treatment of acute myeloid leukaemia

Published: 12 Feb 2024

Citation: Yılmaz S, Bağcı M, Baştürk A. Contributions of ELN2022 update and new genetic analysis tests in the risk assesment and treatment of acute myeloid leukaemia. J Curr Hematol Oncol Res. 2024;2(1):22-23.

_Footer